Top

Journal of Mammary Gland Biology and Neoplasia

Published in:

01-09-2007

Modeling Migration and Metastasis in Drosophila

Authors: Anna C.-C. Jang, Michelle Starz-Gaiano, Denise J. Montell

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 2-3/2007

Abstract

Cell motility makes essential contributions to normal embryonic development and homeostasis. It is also thought to contribute in important ways to tumor metastasis. Because of this dual importance, cell migration has been extensively studied. The fruit fly Drosophila melanogaster has served as an important model organism for genetic analysis of many aspects of developmental biology, including cell migration. Here we describe the various types of cell movements that have been studied in detail, which represent models for epithelial-to-mesenchymal transition, transepithelial migration, inflammation, wound healing and invasion. We summarize what has been learned about the molecular control of cell migration from genetic studies in the fly. In addition, we describe recent efforts to model tumor metastasis directly in Drosophila by expressing oncogenes and/or mutating tumor suppressor genes. Together these studies suggest that Drosophila has much to offer as a model for varied aspects of tumor metastasis.

Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12 8:895–904.PubMedCrossRef

Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980;287 5785:795–801.PubMedCrossRef

Evangelista M, Tian H, de Sauvage FJ. The hedgehog signaling pathway in cancer. Clin Cancer Res 2006;12 20 Pt 1:5924–8.PubMedCrossRef

Leptin M, Grunewald B. Cell shape changes during gastrulation in Drosophila. Development 1990;110 1:73–84.PubMed

Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006;66 9:4549–52.PubMedCrossRef

Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15 6:740–6.PubMedCrossRef

Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17 5:548–58.PubMedCrossRef

Gryzik T, Muller HA. FGF8-like1 and FGF8-like2 encode putative ligands of the FGF receptor Htl and are required for mesoderm migration in the Drosophila gastrula. Curr Biol 2004;14 8:659–67.PubMedCrossRef

Stathopoulos A, Tam B, Ronshaugen M, Frasch M, Levine M. Pyramus and thisbe: FGF genes that pattern the mesoderm of Drosophila embryos. Genes Dev 2004;18 6:687–99.PubMedCrossRef

10.

Kunwar PS, Starz-Gaiano M, Bainton RJ, Heberlein U, Lehmann R. Tre1, a g protein-coupled receptor, directs transepithelial migration of Drosophila germ cells. PLoS Biol 2003;1 3:E80.PubMedCrossRef

11.

Renault AD, Sigal YJ, Morris AJ, Lehmann R. Soma-germ line competition for lipid phosphate uptake regulates germ cell migration and survival. Science 2004;305 5692:1963–6.PubMedCrossRef

12.

Metzger RJ, Krasnow MA. Genetic control of branching morphogenesis. Science 1999;284 5420:1635–9.PubMedCrossRef

13.

Kerman BE, Cheshire AM, Andrew DJ. From fate to function: the Drosophila trachea and salivary gland as models for tubulogenesis. Differentiation 2006;74 7:326–48.PubMedCrossRef

14.

Affolter M, Bellusci S, Itoh N, Shilo B, Thiery JP, Werb Z. Tube or not tube: remodeling epithelial tissues by branching morphogenesis. Dev Cell 2003;4 1:11–8.PubMedCrossRef

15.

Bruckner K, Kockel L, Duchek P, Luque CM, Rorth P, Perrimon N. The PDGF/VEGF receptor controls blood cell survival in Drosophila. Dev Cell 2004;7 1:73–84.PubMedCrossRef

16.

Cho NK, Keyes L, Johnson E, Heller J, Ryner L, Karim F, et al. Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell 2002;108 6:865–76.PubMedCrossRef

17.

Wood W, Faria C, Jacinto A. Distinct mechanisms regulate hemocyte chemotaxis during development and wound healing in Drosophila melanogaster. J Cell Biol 2006;173 3:405–16.PubMedCrossRef

18.

Stramer B, Wood W, Galko MJ, Redd MJ, Jacinto A, Parkhurst SM, et al. Live imaging of wound inflammation in Drosophila embryos reveals key roles for small GTPases during in vivo cell migration. J Cell Biol 2005;168 4:567–73.PubMedCrossRef

19.

Xia Y, Karin M. The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 2004;14 2:94–101.PubMedCrossRef

20.

Vidal M, Cagan RL. Drosophila models for cancer research. Curr Opin Genet Dev 2006;16 1:10–6.PubMedCrossRef

21.

Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005;5 5:355–66.PubMedCrossRef

22.

Silver DL, Geisbrecht ER, Montell DJ. Requirement for JAK/STAT signaling throughout border cell migration in Drosophila. Development 2005;132 15:3483–92.PubMedCrossRef

23.

Silver DL, Montell DJ. Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila. Cell 2001;107 7:831–41.PubMedCrossRef

24.

Montell DJ. Border-cell migration: the race is on. Nat Rev Mol Cell Biol 2003;4 1:13–24.PubMedCrossRef

25.

Montell DJ, Rorth P, Spradling AC. slow border cells, a locus required for a developmentally regulated cell migration during oogenesis, encodes Drosophila C/EBP. Cell 1992;71 1:51–62.PubMedCrossRef

26.

Wang X, Bo J, Bridges T, Dugan KD, Pan TC, Chodosh LA, et al. Analysis of cell migration using whole-genome expression profiling of migratory cells in the Drosophila ovary. Dev Cell 2006;10 4:483–95.PubMedCrossRef

27.

Liu Y, Montell DJ. Identification of mutations that cause cell migration defects in mosaic clones. Development 1999;126 9:1869–78.PubMed

28.

McDonald JA, Pinheiro EM, Kadlec L, Schupbach T, Montell DJ. Multiple EGFR ligands participate in guiding migrating border cells. Dev Biol 2006;296:94–103.PubMedCrossRef

29.

McDonald JA, Pinheiro EM, Montell DJ. PVF1, a PDGF/VEGF homolog, is sufficient to guide border cells and interacts genetically with Taiman. Development 2003;130 15:3469–78.PubMedCrossRef

30.

Duchek P, Rorth P. Guidance of cell migration by EGF receptor signaling during Drosophila oogenesis. Science 2001;291 5501:131–3.PubMedCrossRef

31.

Ferretti G, Felici A, Papaldo P, Fabi A, Cognetti F. HER2/neu role in breast cancer: from a prognostic foe to a predictive friend. Curr Opin Obstet Gynecol 2007;19 1:56–62.PubMedCrossRef

32.

Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65 12:5278–83.PubMedCrossRef

33.

Xue C, Liang F, Mahmood R, Vuolo M, Wyckoff J, Qian H, et al. ErbB3-dependent motility and intravasation in breast cancer metastasis. Cancer Res 2006;66 3:1418–26.PubMedCrossRef

34.

de Launoit Y, Baert JL, Chotteau-Lelievre A, Monte D, Coutte L, Mauen S, et al. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim Biophys Acta 2006;1766 1:79–87.PubMed

35.

Schober M, Rebay I, Perrimon N. Function of the ETS transcription factor Yan in border cell migration. Development 2005;132 15:3493–504.PubMedCrossRef

36.

Niewiadomska P, Godt D, Tepass U. DE-Cadherin is required for intercellular motility during Drosophila oogenesis. J Cell Biol 1999;144 3:533–47.PubMedCrossRef

37.

Bai J, Uehara Y, Montell DJ. Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. Cell 2000;103 7:1047–58.PubMedCrossRef

38.

Pinheiro EM, Montell DJ. Requirement for Par-6 and Bazooka in Drosophila border cell migration. Development 2004;131 21:5243–51.PubMedCrossRef

39.

Montell DJ. Command and control: regulatory pathways controlling invasive behavior of the border cells. Mech Dev 2001;105 1–2:19–25.PubMedCrossRef

40.

Vleminckx K, Vakaet L, Jr., Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66 1:107–19.PubMedCrossRef

41.

Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13 9:1919–25.PubMed

42.

Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005;17 5:499–508.PubMedCrossRef

43.

Geisbrecht ER, Montell DJ. Myosin VI is required for E-cadherin-mediated border cell migration. Nat Cell Biol 2002;4 8:616–20.PubMed

44.

Yoshida H, Cheng W, Hung J, Montell D, Geisbrecht E, Rosen D, et al. Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer. Proc Natl Acad Sci U S A 2004;101 21:8144–9.PubMedCrossRef

45.

Dunn TA, Chen S, Faith DA, Hicks JL, Platz EA, Chen Y, et al. A novel role of myosin VI in human prostate cancer. Am J Pathol 2006;169 5:1843–54.PubMedCrossRef

46.

Carney GE, Bender M. The Drosophila ecdysone receptor (EcR) gene is required maternally for normal oogenesis. Genetics 2000;154 3:1203–11.PubMed

47.

Cherbas L, Hu X, Zhimulev I, Belyaeva E, Cherbas P. EcR isoforms in Drosophila: testing tissue-specific requirements by targeted blockade and rescue. Development 2003;130 2:271–84.PubMedCrossRef

48.

Torres-Arzayus MI, Yuan J, DellaGatta JL, Lane H, Kung AL, Brown M. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland. Cancer Res 2006;66 23:11381–8.PubMedCrossRef

49.

Kuang SQ, Liao L, Wang S, Medina D, O’Malley BW, Xu J. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res 2005;65 17:7993–8002.PubMed

50.

Yoshida H, Liu J, Samuel S, Cheng W, Rosen D, Naora H. Steroid receptor coactivator-3, a homolog of Taiman that controls cell migration in the Drosophila ovary, regulates migration of human ovarian cancer cells. Mol Cell Endocrinol 2005;245 1–2:77–85.PubMedCrossRef

51.

Oh A, List HJ, Reiter R, Mani A, Zhang Y, Gehan E, et al. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res 2004;64 22:8299–308.PubMedCrossRef

52.

Roy M, Pear WS, Aster JC. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 2007;17 1:52–9.PubMedCrossRef

53.

Edenfeld G, Volohonsky G, Krukkert K, Naffin E, Lammel U, Grimm A, et al. The splicing factor crooked neck associates with the RNA-binding protein HOW to control glial cell maturation in Drosophila. Neuron 2006;52 6:969–80.PubMedCrossRef

54.

Lopez-Schier H, St Johnston D. Delta signaling from the germ line controls the proliferation and differentiation of the somatic follicle cells during Drosophila oogenesis. Genes Dev 2001;15 11:1393–405.PubMedCrossRef

55.

Wang X, Adam JC, Montell D. Spatially localized Kuzbanian required for specific activation of Notch during border cell migration. Dev Biol 2007;301 2:532–40.PubMedCrossRef

56.

Callahan R, Egan SE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004;9 2:145–63.PubMedCrossRef

57.

Humbert PO, Dow LE, Russell SM. The Scribble and Par complexes in polarity and migration: friends or foes? Trends Cell Biol 2006;16 12:622–30.PubMedCrossRef

58.

Dow LE, Kauffman JS, Caddy J, Peterson AS, Jane SM, Russell SM, et al. The tumour-suppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge. Oncogene 2007;26:2272–82.PubMedCrossRef

59.

Grifoni D, Garoia F, Schimanski CC, Schmitz G, Laurenti E, Galle PR, et al. The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo. Oncogene 2004;23 53:8688–94.PubMedCrossRef

60.

Handa K, Yugawa T, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T. E6AP-Dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol 2007;81 3:1379–89.PubMedCrossRef

61.

Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev 2004;18 16:1909–25.PubMedCrossRef

62.

Nagasaka K, Nakagawa S, Yano T, Takizawa S, Matsumoto Y, Tsuruga T, et al. Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells. Cancer Sci 2006;97 11:1217–25.PubMedCrossRef

63.

Nguyen MM, Nguyen ML, Caruana G, Bernstein A, Lambert PF, Griep AE. Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol Cell Biol 2003;23 24:8970–81.PubMedCrossRef

64.

Goode S, Perrimon N. Brainiac and fringe are similar pioneer proteins that impart specificity to Notch signaling during Drosophila development. Cold Spring Harb Symp Quant Biol 1997;62:177–84.PubMed

65.

Abdelilah-Seyfried S, Cox DN, Jan YN. Bazooka is a permissive factor for the invasive behavior of discs large tumor cells in Drosophila ovarian follicular epithelia. Development 2003;130 9:1927–35.PubMedCrossRef

66.

Szafranski P, Goode S. A Fasciclin 2 morphogenetic switch organizes epithelial cell cluster polarity and motility. Development 2004;131 9:2023–36.PubMedCrossRef

67.

Szafranski P, Goode S. Basolateral junctions are sufficient to suppress epithelial invasion during Drosophila oogenesis. Dev Dyn 2007;236 2:364–73.PubMedCrossRef

68.

Beaucher M, Hersperger E, Page-McCaw A, Shearn A. Metastatic ability of Drosophila tumors depends on MMP activity. Dev Biol 2007;303 2:625–34.

69.

Beaucher M, Goodliffe J, Hersperger E, Trunova S, Frydman H, Shearn A. Drosophila brain tumor metastases express both neuronal and glial cell type markers. Dev Biol 2007;301 1:287–97.PubMedCrossRef

70.

Woodhouse EC, Fisher A, Bandle RW, Bryant-Greenwood B, Charboneau L, Petricoin EF, 3rd, et al. Drosophila screening model for metastasis: semaphorin 5c is required for l(2)gl cancer phenotype. Proc Natl Acad Sci U S A 2003;100 20:11463–8.PubMedCrossRef

71.

Eulenberg KG, Schuh R. The tracheae defective gene encodes a bZIP protein that controls tracheal cell movement during Drosophila embryogenesis. EMBO J 1997;16 23:7156–65.PubMedCrossRef

72.

Lie YS, Macdonald PM. Apontic binds the translational repressor Bruno and is implicated in regulation of oskar mRNA translation. Development 1999;126 6:1129–38.PubMed

73.

Brumby AM, Richardson HE. Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer 2005;5 8:626–39.PubMedCrossRef

74.

Pagliarini RA, Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003;302 5648:1227–31.PubMedCrossRef

75.

Uhlirova M, Jasper H, Bohmann D. Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model. Proc Natl Acad Sci U S A 2005;102 37:13123–8.PubMedCrossRef

76.

Igaki T, Pagliarini RA, Xu T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 2006;16 11:1139–46.PubMedCrossRef

77.

Zhang S, Dailey GM, Kwan E, Glasheen BM, Sroga GE, Page-McCaw A. An MMP liberates the Ninjurin A ectodomain to signal a loss of cell adhesion. Genes Dev 2006;20 14:1899–910.PubMedCrossRef

78.

Uhlirova M, Bohmann D. JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. EMBO J 2006;25 22:5294–304.PubMedCrossRef

79.

Pereira PS, Teixeira A, Pinho S, Ferreira P, Fernandes J, Oliveira C, et al. E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia. Hum Mol Genet 2006;15 10:1704–12.PubMedCrossRef

80.

Michelson AM, Gisselbrecht S, Zhou Y, Baek KH, Buff EM. Dual functions of the heartless fibroblast growth factor receptor in development of the Drosophila embryonic mesoderm. Dev Genet 1998;22 3:212–29.PubMedCrossRef

81.

Duchek P, Somogyi K, Jekely G, Beccari S, Rorth P. Guidance of cell migration by the Drosophila PDGF/VEGF receptor. Cell 2001;107 1:17–26.PubMedCrossRef

Title: Modeling Migration and Metastasis in Drosophila
Authors: Anna C.-C. Jang
Michelle Starz-Gaiano
Denise J. Montell
Publication date: 01-09-2007
Publisher: Springer US
Published in: Journal of Mammary Gland Biology and Neoplasia / Issue 2-3/2007
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI: https://doi.org/10.1007/s10911-007-9042-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2-3/2007

MTA Family of Transcriptional Metaregulators in Mammary Gland Morphogenesis and Breast Cancer

Modeling Metastatic Breast Cancer in Mice

Differential Cadherin Expression: Potential Markers for Epithelial to Mesenchymal Transformation During Tumor Progression

Multifaceted Roles of Integrins in Breast Cancer Metastasis

Metastasis Suppressors and Their Roles in Breast Carcinoma

Breast Cancer Progression: Controversies and Consensus in the Molecular Mechanisms of Metastasis and EMT

Keynote webinar | Spotlight on antibody–drug conjugates in cancer